Landscapes / Companies

Adlai Nortye Biopharma Co., Ltd. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 1
 
Next date
AN4005, Phase 1 trial completes
Drugs
4
in active trials · 8 in all
Trials
4 active
10 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
—
Phase 1 Nov 2026soonPhase 1 trial completes
—
Phase 1 Jul 2027Phase 1 trial completes
—
Phase 1 31 Jan 2028Phase 1 trial completes
—
Phase 1 31 Dec 2028Phase 1 trial completes

About

No active trial
AN0025, AN2025, Buparlisib & Paclitaxel, folinic acid/5-FU/oxaliplatin
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Adlai Nortye Biopharma Co., Ltd.

Following is part of Solo: you see every change to Adlai Nortye Biopharma Co., Ltd. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in